News & Events

As spring ushers in a new beginning, everything is renewed with vitality. On March 6, 2026, Hillgene successfully held its Spring Gala themed “Upgrading Capabilities · Expanding Horizons · Shaping ...

March 2026 — Global Biotech NewsLentiviral vector technology continues to play a central role in the evolution of CAR-T cell therapies, as researchers advance strategies aimed at delivering chimeric ...

On February 19, 2026, Japan's Ministry of Health, Labour and Welfare (MHLW) granted conditional and time-limited approval to the world's first two induced pluripotent stem cell (iPSC)–based r...

February 2026 — Global Biotech NewsShanghai, China / Global — CARsgen Therapeutics Holdings Ltd., a clinical-stage biotechnology company focused on innovative chimeric antigen receptor T-cell (CAR-T...

February 2026 — Industry NewsThe global cell and gene therapy (CGT) sector continues to expand, with recent industry data highlighting a combination of strong product revenues, increasing regulatory ...

February 2026 — Global Biotech NewsSan Francisco, CA / USA — The U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application for SRN-101, an AAV-based immuno-ge...

February 2, 2026 — Global Biotech NewsSilver Spring, MD, USA — Senior officials at the U.S. Food and Drug Administration (FDA) have urged biotechnology companies to implement long-term monitoring of...

January 2026Sarepta Therapeutics announced new three-year follow-up data showing that its Duchenne muscular dystrophy (DMD) gene therapy Elevidys (delandistrogene moxeparvovec) continued to demonstrat...

January 25, 2026 — Global Biotech NewsCopenhagen, Denmark / Vancouver, Canada — Danish pharmaceutical giant Novo Nordisk A/S has announced an expansion of its strategic collaboration with Canadian...

January 2026A pivotal Phase III cell therapy clinical trial evaluating a novel donor-derived dopamine-producing cell therapy has commenced enrollment across multiple countries, including Australia, Ca...

January 2026 — Industry NewsThe Asia-Pacific gene therapy market is projected to experience rapid growth over the next decade, with market size expected to reach approximately US$14.59 billion by 20...

January 13, 2026The U.S. Food and Drug Administration (FDA) has declined to approve Atara Biotherapeutics’ cell therapy tabelecleucel for the treatment of Epstein-Barr virus positive post-transplant ...